Cefsulodin is a third-generation cephalosporin antibiotic primarily utilized to treat infections caused by Gram-negative bacteria, particularly Pseudomonas aeruginosa. This antibiotic functions by inhibiting… Read more
Cefsulodin is a third-generation cephalosporin antibiotic primarily utilized to treat infections caused by Gram-negative bacteria, particularly Pseudomonas aeruginosa. This antibiotic functions by inhibiting bacterial cell wall synthesis through the binding of penicillin-binding proteins, and it is also frequently employed in selective culture media to isolate Yersinia microorganisms. To support the rigorous demands of pharmaceutical research and development, this category provides a range of essential compounds, including Cefsulodin reference standards, identified impurities, and metabolites. Pharmaceutical laboratories utilize these materials for precise impurity profiling, method validation, and stability testing. Furthermore, stable isotope labelled compounds are available to serve as internal standards in advanced analytical testing and quality control workflows, ensuring accurate quantification and compliance with regulatory standards across the drug development lifecycle.